You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR TRIOSTAT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TRIOSTAT

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00027417 ↗	Study of Triostat in Infants During Heart Surgery	Completed	Michael Portman	Phase 3	2001-04-01	This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.
NCT02320669 ↗	Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass	Unknown status	Seattle Children's Hospital	Phase 3	2014-11-01	This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery. Funding Source - FDA OOPD.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TRIOSTAT

Condition Name

Chart
Table

Condition Name for TRIOSTAT
Intervention	Trials
Congenital Heart Defects	1
Heart Defects, Congenital	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TRIOSTAT
Intervention	Trials
Heart Defects, Congenital	2
Congenital Abnormalities	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TRIOSTAT

Trials by Country

Map
Table

Trials by Country for TRIOSTAT
Location	Trials
United States	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TRIOSTAT
Location	Trials
Washington	2
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TRIOSTAT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TRIOSTAT
Clinical Trial Phase	Trials
Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TRIOSTAT
Clinical Trial Phase	Trials
Completed	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRIOSTAT

Sponsor Name

Chart
Table

Sponsor Name for TRIOSTAT
Sponsor	Trials
Michael Portman	1
Seattle Children's Hospital	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TRIOSTAT
Sponsor	Trials
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.